Cannabis News
Inside a Chinese Run Illegal Cannabis Farm
In the ongoing saga of drug prohibition, cannabis stands as a prime example of the unintended consequences that arise when governments attempt to suppress substances deemed illicit. The very act of prohibition, designed to reduce consumption, production, and distribution, has instead created a thriving black market that attracts criminal enterprises from around the globe.
When a substance is prohibited, it becomes contraband, inherently increasing its value to those willing to pay for it. This inflated value, in turn, entices individuals to risk their freedom to supply the illicit good. The result is a multi-billion dollar underground economy fueled by the illegal drug trade, with cannabis being one of its most lucrative commodities.
For decades, Mexican cartels dominated the illegal cannabis market in the United States. However, a new player has emerged on the scene, rapidly outpacing their predecessors: Chinese criminal organizations. These groups have established a network of illegal cannabis farms across the country, exploiting vulnerable workers and flooding the market with unregulated products.
In this article, we’ll delve into the harrowing experience of one individual who escaped from a Chinese-run illegal cannabis farm, shedding light on the brutal realities of this underground industry. We’ll explore the prevalence of these operations in the United States and examine how Chinese groups have managed to surpass Mexican cartels in the illegal cannabis trade.
Most importantly, we’ll discuss how full-scale legalization and decriminalization of cannabis could effectively combat these illegal operations, protect workers, ensure product safety, and redirect billions of dollars from criminal enterprises to legitimate businesses and tax coffers. The story that follows serves as a stark reminder of the human cost of prohibition and the urgent need for comprehensive drug policy reform.
Lin’s harrowing experience on an illegal Chinese-run cannabis farm in Oklahoma serves as a stark reminder of the dark underbelly of prohibition. As reported by The Frontier and ProPublica, Lin, a 44-year-old Chinese immigrant, found himself staring down the barrel of an AK-47 when he dared to demand unpaid wages from his ruthless employers. This terrifying incident forced Lin and his wife to flee to New York, but even three years later, the couple lives in constant fear of retribution.
Lin’s story is not unique. He was one of several dozen Chinese immigrants working without pay on the farm, intimidated into silence by armed guards and violent managers. The farm’s owner, Lamkam Ho, and manager, Zhixuan Hai, have since faced legal consequences for their involvement in marijuana trafficking and other crimes. However, the broader issue of exploitative labor practices in illegal cannabis operations persists.
What drives individuals like Lin to take such risks? For many, it’s a combination of desperation and deception. Lin initially left China due to religious persecution, paying smugglers $50,000 to escape. When the pandemic disrupted his life in New York, the promise of work on cannabis farms seemed like a lifeline. But for others, the situation is even more dire. Many workers on these farms are victims of human trafficking, sold into modern-day slavery with little hope of escape.
The prevalence of Chinese-run illegal cannabis operations in the United States has skyrocketed in recent years. These criminal organizations have quickly outpaced Mexican cartels, establishing a vast network of illicit farms across multiple states. What’s particularly alarming is the suspected connection between these criminal groups and the Chinese Communist Party (CCP).
This connection transforms the issue from a domestic law enforcement problem into a matter of national security. These operations aren’t just flooding the U.S. market with unregulated cannabis; they’re funneling billions of dollars out of the American economy and into the coffers of a foreign government. The scale of this problem is staggering, with thousands of Chinese immigrant laborers subjected to abuse and exploitation across the country.
The rapid expansion of Chinese-run cannabis farms in the U.S. has caught many by surprise. Law enforcement agencies, already stretched thin, struggle to keep up with the proliferation of these operations. The sophisticated nature of these criminal networks, often leveraging high-tech equipment and complex financial structures, makes them particularly challenging to combat.
Perhaps most troubling is the apparent inaction from politicians and policymakers. Whether due to ignorance, indifference, or more sinister motivations, the lack of decisive action against these operations is allowing the problem to grow unchecked. This inaction not only perpetuates human rights abuses but also poses a significant threat to America’s economic and national security interests.
The story of Lin and the broader issue of Chinese-run illegal cannabis farms underscore the urgent need for comprehensive cannabis legalization and decriminalization. By bringing the industry into the light, we can eliminate the shadows where criminal enterprises thrive, protect vulnerable workers, ensure product safety, and redirect billions of dollars from illicit operations to legitimate businesses and tax revenue. The human cost of prohibition is too high, and the threats to national security too great, to continue down the current path. It’s time for a dramatic shift in U.S. drug policy, one that prioritizes public health, worker safety, and national interests over outdated and ineffective prohibitionist approaches.
Drug prohibition, while ostensibly aimed at reducing substance abuse and associated crimes, often serves as a smoke screen, obscuring far more insidious activities that thrive in its shadow. This veil of illegality doesn’t just fail to curb drug use; it creates a fertile ground for a myriad of other criminal enterprises to flourish.
A prime example of this came to light in 2012 when major financial institutions like HSBC and Bank of America were implicated in large-scale money laundering operations tied to drug cartels. HSBC, for instance, admitted to laundering nearly $900 million for Mexico’s notorious Sinaloa Cartel. Yet, the punishment for these banks amounted to little more than a slap on the wrist – fines that pale in comparison to the profits reaped from these illicit activities. This incident exposed how deeply entrenched drug money is in our global financial system, with some of the world’s most respected banks willingly turning a blind eye to the source of billions of dollars.
Moreover, the focus on drug interdiction often diverts attention and resources from other serious crimes. Human trafficking, for instance, frequently operates under the cover of drug networks. While law enforcement agencies pour resources into drug busts, human traffickers exploit the chaos and corruption bred by prohibition to conduct their operations with relative impunity. The result is a cruel irony: in our zeal to protect people from drugs, we inadvertently create conditions that subject many to modern-day slavery.
This reality underscores why drug legalization and regulation may be the most effective approach for the long-term well-being of society. While it’s true that some drugs can have negative impacts on individuals and communities – alcohol being a prime example – the societal costs of regulated legal use are far outweighed by the violence, corruption, and human rights abuses that accompany prohibition.
We need only look at the history of alcohol prohibition in the United States to see this principle in action. The era of speakeasies and bootleggers was marked by a surge in organized crime, corruption, and violence. Once alcohol was relegalized and regulated, these problems didn’t disappear overnight, but they were significantly reduced. The power of criminal organizations was diminished, and the government gained a new source of tax revenue.
By bringing the drug trade out of the shadows, we can redirect the flow of money from criminal enterprises back to legitimate businesses and public coffers. Instead of enriching cartels and fueling violence, drug revenues could fund education, healthcare, and addiction treatment programs. Regulation would also ensure product safety, reducing the risks associated with contaminated or adulterated substances.
Furthermore, legalization would free up vast law enforcement resources currently dedicated to fighting an unwinnable war on drugs. These resources could be redirected to combat more serious crimes, including human trafficking and other forms of exploitation that currently thrive in the chaos of the illegal drug trade.
The smoke screen of drug prohibition has allowed too many grave injustices to persist unchallenged. It’s time to clear the air. By embracing a policy of legalization and regulation, we can strike at the heart of criminal enterprises, protect vulnerable populations, and create a safer, more just society. The choice is clear: we can continue to fight a losing battle against drugs, or we can take bold steps to address the real problems that prohibition has long obscured.
Lin’s harrowing experience on an illegal Chinese-run cannabis farm in Oklahoma is not an isolated incident, but a stark illustration of a much larger, systemic problem. His story serves as a grim reminder of the human cost of our current drug policies, particularly cannabis prohibition. While Lin managed to escape, countless others remain trapped in similar situations, victims of a system that pushes an entire industry into the shadows.
The truth is, cannabis legalization – and indeed, the legalization of all drugs – is the only viable path forward if we truly want to address these issues. Prohibition has failed spectacularly in its stated goals of reducing drug use and associated crimes. Instead, it has created a thriving black market, fueled violence, enabled human trafficking, and allowed criminal enterprises to amass enormous wealth and power.
This October, the DEA aims to reschedule cannabis, potentially moving it from Schedule I to Schedule III. While this might seem like progress on the surface, it falls woefully short of what’s needed. This half-measure will do nothing for people like Lin and millions of others caught in the crossfire of prohibition. It won’t dismantle the illegal operations that exploit vulnerable workers, it won’t ensure product safety for consumers, and it won’t redirect the billions of dollars currently flowing into criminal enterprises.
What we need is a complete revamp of the system. Full legalization and regulation of cannabis – and eventually all drugs – would strip power from criminal organizations, protect workers, ensure product safety, generate tax revenue, and allow law enforcement to focus on real crimes like human trafficking. It would bring an entire industry out of the shadows and into the light of legal scrutiny and worker protections.
The sticky bottom line is this: our current approach to drug policy is not just failing – it’s actively harmful. It creates more problems than it solves, victimizing vulnerable populations and enriching criminal enterprises. The story of Lin and countless others like him should serve as a wake-up call. It’s time to abandon the failed policies of the past and embrace a new approach based on science, public health, and human rights.
Legalization is not just about the right to use cannabis or other substances. It’s about dismantling a system that enables exploitation, violence, and corruption. It’s about protecting vulnerable workers, ensuring consumer safety, and redirecting billions of dollars from criminal enterprises to public benefit. It’s about recognizing that the “war on drugs” has been a war on people – particularly marginalized communities – and it’s time for it to end.
As we move forward, let’s keep Lin’s story in mind. Let’s remember that behind every illegal cannabis operation are real people suffering real harm. And let’s commit to creating a system that prioritizes human dignity, public health, and social justice over outdated, ineffective, and harmful prohibitionist policies. The time for half-measures is over. The time for real, comprehensive drug policy reform is now.
HUMAN TRAFFICKING IN THE CANNABIS INDUSTRY, READ THIS…
Cannabis News
US Court Rules Delta-8 THC Derived from Hemp is 100% Legal, Slamming the DEA in Embarrassing Court Case
In a groundbreaking decision, the U.S. Court of Appeals for the Ninth Circuit has ruled that Delta-8 tetrahydrocannabinol (Delta-8 THC) derived from legal hemp sources is not classified as a controlled substance under federal law, directly contradicting the Drug Enforcement Administration’s (DEA) position that all synthetically derived tetrahydrocannabinols, including Delta-8 THC, fall under Schedule I controlled substances. This landmark ruling emerged from a case brought forward by several key players in the hemp industry who challenged the DEA’s interpretation of the 2018 Farm Bill, which legalized hemp and its derivatives. The court’s decision not only rejects the DEA’s restrictive stance but also provides much-needed clarity regarding the legal status of Delta-8 THC, allowing for its continued production and sale from legally sourced hemp. This ruling is significant as it has the potential to reshape the regulatory landscape for cannabinoids, encouraging further exploration and commercialization of hemp-derived products while also highlighting the ongoing tensions between federal regulations and the rapidly evolving hemp industry.
Delta-8 THC: A Naturally Occurring Cannabinoid
Delta-8 tetrahydrocannabinol (Delta-8 THC) is a naturally occurring cannabinoid found in trace amounts in hemp and cannabis plants that shares a similar molecular structure to Delta-9 THC, the primary psychoactive compound in marijuana, but is known to produce significantly milder intoxicating effects; the 2018 Farm Bill’s legalization of hemp and its derivatives containing no more than 0.3% Delta-9 THC on a dry weight basis created a legal gray area for Delta-8 THC, which has proliferated in the form of various products derived from legal hemp sources and sold in a largely unregulated market, as they are not explicitly classified as controlled substances by the Drug Enforcement Administration (DEA) despite the agency’s stance that all synthetically derived tetrahydrocannabinols should be treated as Schedule I drugs regardless of their origin or potency, a position that has been challenged by hemp industry players arguing that Delta-8 THC from legal hemp should be exempt from the same restrictions as Delta-9 THC.
The DEA’s Stance and Industry Challenges
The Drug Enforcement Administration (DEA) has taken a firm stance that all synthetically derived tetrahydrocannabinols, including Delta-8 THC, are classified as Schedule I controlled substances under the Controlled Substances Act (CSA), regardless of their source or concentration. This position has faced considerable resistance from various stakeholders within the hemp industry, who argue that Delta-8 THC derived from legal hemp should not be subjected to the same stringent restrictions as Delta-9 THC, the primary psychoactive compound in marijuana. Proponents contend that the 2018 Farm Bill, which legalized hemp and its derivatives, should extend to include Delta-8 THC, allowing it to be treated as a legal product when sourced from hemp that contains less than 0.3% Delta-9 THC. They emphasize that while Delta-8 THC may occur naturally in small amounts in hemp, the majority of Delta-8 products on the market are produced through a chemical conversion process from CBD, which the DEA argues renders them synthetic and thus illegal. This conflict has led to ongoing legal challenges, with some courts ruling in favor of the hemp industry, asserting that Delta-8 THC should not be classified as a controlled substance when derived from legal hemp. As the debate continues, the tension between the DEA’s regulatory framework and the evolving hemp market raises critical questions about the future of cannabinoid regulation in the United States.
The Court’s Ruling and Its Implications
The U.S. Court of Appeals for the Ninth Circuit ruled that Delta-8 THC derived from legal hemp sources is not controlled substance.
-
The court found the DEA’s interpretation of the law was “arbitrary and capricious” and lacked a reasoned explanation.
-
This ruling effectively removes Delta-8 THC from the DEA’s list of controlled substances, provided it is derived from hemp containing less than 0.3% Delta-9 THC.
-
The decision provides legal protection for businesses and consumers involved in Delta-8 THC products derived from legal hemp sources.
Opportunities for the Hemp and Cannabis Industries
The recent court ruling represents a significant victory for the hemp and cannabis industries, paving the way for new possibilities in product development and research.
-
Therapeutic Potential: Delta-8 THC has been recognized for its potential therapeutic benefits, which could attract more consumers seeking alternative treatments.
-
Increased Investment: The legalization of Delta-8 THC may lead to heightened investment and innovation within the sector, encouraging the development of new products and formulations.
-
Regulatory Concerns: Despite the positive implications, the ruling also raises important concerns regarding the regulation and quality control of Delta-8 THC products, necessitating careful oversight.
-
Need for Standards: As the market for Delta-8 THC expands, there will be a pressing need for clear guidelines and standards to ensure consumer safety and product consistency, helping to build trust in these emerging products.
Broader Implications for Cannabis Legalization
The court’s ruling underscores the ongoing conflict between federal and state laws concerning the regulation of cannabis and its derivatives.
-
Increasing State Legalization: As more states advance toward the legalization of both recreational and medical marijuana, the pressure on the federal government to revise its policies and align them with shifting public opinion is likely to intensify.
-
Step Forward for Delta-8 THC: The ruling regarding Delta-8 THC may be viewed as a positive development in the broader context of cannabis legalization, yet significant challenges remain.
-
Path to Comprehensive Legalization: There is still a considerable distance to cover before achieving comprehensive federal legalization of cannabis, highlighting the complexities of navigating cannabis policy in the United States.
Conclusion
The court’s ruling underscores the ongoing conflict between federal and state laws concerning the regulation of cannabis and its derivatives. As more states advance toward the legalization of both recreational and medical marijuana, the pressure on the federal government to revise its policies and align them with shifting public opinion is likely to intensify. The ruling regarding Delta-8 THC may be viewed as a positive development in the broader context of cannabis legalization; however, significant challenges remain, and there is still a considerable distance to cover before achieving comprehensive federal legalization of cannabis, highlighting the complexities of navigating cannabis policy in the United States.
DELTA-8 THC IS LEGAL, READ MORE…
Metabolic syndrome is an umbrella term referring to several conditions that negatively impact how the body metabolizes carbohydrates, fats, and proteins.
It occurs when there are unusual, abnormal chemical processes in the body which affect otherwise healthy metabolic functions. The primary symptoms of metabolic syndrome include abdominal fat, high blood pressure, high blood sugar, high triglycerides, and low levels of LDL (good) cholesterol. These conditions all greatly increase the risk of stroke, coronary heart disease, diabetes, and other severe health issues that are difficult or near impossible to reverse.
The most telling symptom, though, is a large waist circumference – and you don’t need to take any kind of medical test to tell you this because it’s completely visible.
That’s why prevention is key when it comes to metabolic syndrome. However, the choices you make on a daily basis in your lifestyle can determine your risk for metabolic syndrome of not. We know that an unhealthy diet that is high in sugar, salt, and processed food can contribute to the symptoms of metabolic syndrome. A sedentary lifestyle, obesity, poor sleep hygiene, and exposure to chronic stress can also make the risk much worse. Smoking tobacco and alcohol are even worse – don’t even think about it.
But cannabis? That can actually help!
What Studies Say
A recent study that was published in the American Journal of Open Medicine found that young adults with a habit of consuming cannabis had a significantly lower prevalence of metabolic syndrome. For the study, investigators from the University of Miami analyzed a cohort of almost 4,000 individuals whose ages ranged from 18 to 25. They specifically zoned in on the young adults’ cannabis use.
They found that current cannabis users were 42% less likely to have metabolic syndrome. They also found that Non-Hispanic Blacks, who were consuming more weed than the other subjects, were found to be the least likely of all to have metabolic syndrome. “Current cannabis users had a lower prevalence of MetS, predominantly noted among NHB (non-Hispanic Blacks], the group with the highest prevalence of current cannabis use,” said the study’s authors. “Future prospective studies are warranted to examine the role of specific cannabinoids on MetS by race/ethnicity,” they said.
A Smaller Waist Circumference: Why You Should Pay Attention, And How Weed Can Help
Having a large waist circumference or a visibly fatty belly has been associated with numerous health conditions. Of course, this includes a heightened risk of metabolic disease. It also increases the risk of inflammation, type 2 diabetes, cardiovascular disease incidence, and cancer among others.
That is why it’s critical to pay attention to the size of your stomach. A smaller waist means you have a smaller amount of visceral fat, which is necessary for better health and an improved quality of life.
There are many steps you can take to reduce your visceral fat. These include:
-
Sticking to a low carbohydrate and low sugar diet
-
Having a diet high in good protein sources
-
Reduce consumption of trans fat and saturated fats
-
Engage in strength training and cardiovascular exercises
-
Manage stress effectively
Last but not the least: did you know that consuming cannabis has been shown to be associated with smaller waistlines and a reduced risk for obesity?
In 2020, a study out of Quebec in Canada revealed that cannabis consumption was linked to a smaller waist and reduced triglyceride levels. For this study, the investigator in Canada analyzed subjects who either never consumed marijuana in the past, used it sometime in the past but had no recent use, had some infrequent use, or consume it infrequently. They specifically measured the participants’ waist circumference and triglycerides.
They found out that the subjects who consumed certain marijuana strains for metabolic syndrome for at least 4 days per week were found to have smaller waistlines as well as less triglycerides compared to the other participants in the study.
Another study from 2015, also out of Quebec, was conducted by researchers from the Conference of Quebec University Health Centers. They analyzed cannabis consumption patterns of 786 Arctic aboriginal adults, the Inuits. The investigators also analyzed their body mass index to search for any links between cannabis use and BMI.
They found that study participants who consumed marijuana within the last year were more likely to have a lower body mass index, as well as reduced fasting insulin and better insulin resistance (using the HOMA-IR indicator) compared to those who did not.
“In this large cross-sectional adult survey with high prevalence of both substance use and obesity, cannabis use in the past year was associated with lower BMI, lower percentage fat mass, lower fasting insulin, and HOMA-IR,” said the researchers. In other words, they observed a relationship between cannabis use and BMI that led them to conclude that cannabis and cannabinoid use can help consumers reduce the likelihood of obesity and diabetes.
Meanwhile, an older study from 2013 also had similar results. Research data from The American Journal of Medicine taken from more than 4,600 patients yielded interesting findings. Almost 45% of patients never consumed marijuana in their lives, while 43% of them smoked in the past though no longer do currently. And 12% of them were regular cannabis users.
Researchers discovered that cannabis users who consumed marijuana within the past month had 16% less fasting insulin levels compared to those who never consumed weed. In addition, they even add reduced HOMA-IR levels and higher high-density lipoprotein. Furthermore, the investigators found that regular cannabis users who usually consume more calories, they also had lower BMI’s.
Conclusion
Staying fit and healthy is much more than vanity: science and medical research makes it clear that there is a strong link between obesity and body mass index, to overall health and wellness. Metabolic syndrome further emphasizes the importance of keeping one’s BMI normal, and based on these studies, that’s something cannabis can help with. Integrating responsible cannabis use into your lifestyle is one tool out of many that can help you stay healthy and reduce the risks of developing metabolic syndrome.
MORE ON METABOLIC SYNDROME AND WEED, READ ON…
Tips For Guys To Get A Dating App Response
A Fun Habit Can Help Calm Anxiety
Trying to expand a cannabis business, surrounded by moratoriums
Ousted Shannon O’Brien vows legal battle over pot board firing
Good Grades: 3 things I can’t smoke without
Cannabis Control Commission to Host Public Comment Period, Hybrid Hearing on Amendments to Microbusinesses, Delivery, Telehealth Regulations
‘I visited Snoop Dogg’s new pungent European cannabis café tucked down an unlikely street’
New York City-Based Dispensary Wants to Buy back Your Illegal Weed
Buying Cannabis Without Identification – GanjaVacations Jamaica
A Green Solution for Our Environment and Industries
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
City Of Oakland Issues RFP For Employee Training Programs
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
-
Cannabis News1 year agoDistressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders1 year agoUnited States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years agoWhat you Need to Know
-
drug testing9 months agoDrug Testing for Marijuana – The Joint Blog
-
Marijuana Business Daily1 year agoCannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
Education2 years agoNCIA Write About Their Equity Scholarship Program
-
Cannabis1 year agoIt has been a wild news week – here’s how CBD and weed can help you relax
-
Education1 year agoCity Of Oakland Issues RFP For Employee Training Programs